Member Login
  1. Stocks
    2. /
  2. HUTCHMED (LSE: HCM)
    3. /

LSE:HCM (HUTCHMED)

About HCM

HUTCHMED (Nasdaq/AIM: HCM; HKEX: 13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Since inception it has focused on bringing drug candidates from in-house discovery to patients around the world, with its first three medicines marketed in China, the first of which is also approved around the world including in the US, Europe and Japan.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

HUTCHMED (LSE: HCM) Latest News

Investing Articles

Should You Buy Hikma Pharmaceuticals Plc, Circassia Pharmaceuticals PLC & Hutchison China MediTech Limited On Today’s News?

| G A Chester

Can Hikma Pharmaceuticals Plc (LON:HIK), Circassia Pharmaceuticals PLC (LON:CIR) and Hutchison China MediTech Limited (LON:HCM) boost your portfolio?

Read more »

Investing Articles

Why GlaxoSmithKline plc And Hutchison China MediTech Limited Are A Perfect Pairing

| G A Chester

G A Chester reckons pairing GlaxoSmithKline plc (LON:GSK) with Hutchison China MediTech Limited (LON:HCM) could be a smart move.

Read more »

Investing Articles

Should You Follow Directors Buying At Monitise Plc, Hutchison China MediTech Limited And Tungsten Corp PLC?

| G A Chester

Is it time to invest in Monitise Plc (LON:MONI), Hutchison China MediTech Limited (LON:HCM) and Tungsten Corp PLC (LON:TUNG) after…

Read more »